InvestorsHub Logo
Followers 4
Posts 1242
Boards Moderated 0
Alias Born 01/16/2016

Re: Bobby Marinov post# 6343

Tuesday, 03/24/2020 4:37:42 PM

Tuesday, March 24, 2020 4:37:42 PM

Post# of 6602
"Is it the responsibility of the investor to memorize what each company in the field means by its marketing material?"

Yes, it is the responsibility of the investor to do their own due diligence. How much investors are able to look past the balance sheet and into the science/terminology of exoskeleton usage is a good question.

To me, what you speak of is exactly why the Kindred Healthcare pilot of EksoNR in Ltac hospitals is such an important milestone for Ekso Bionics. I think this specific example showcases why Ekso is not alone. Instead of Ekso having to fund their own research, others are pushing Ekso into new domains via pilot while Ekso gets to make money while doing it. This is radical for Ekso and to me it's a really, really good sign.

In the industrial vest space: weight, cost, lift assistance, warranty, availability are some basic metrics that come to mind. It would be nice to see more ergonomics: for instance some sort of standardized 'average external forces' for normal use. It'll be interesting to see post-pilot acquisitions and if they create a pattern.

I'm long EKSO
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent EKSO News